NVAX Financial Facts

Research and development: 64.9M
Interest income: 670K
See Full Income Statement

Deferred revenue: 32.81M
Accrued expenses and other current liabilities: 26.52M
See Full Balance Sheet

Novavax, Inc. (NVAX) Earnings

  |   Expand Research on NVAX
Next EPS Date 11/9/16 *Est. EPS Growth Rate -262.5% *Last Qtr.
Average EPS % Beat Rate -41.0% Revenue Growth Rate -82.1% *Last Qtr.
Average % Move 1-Wk after EPS -5.6% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/10/15 Q215 -$0.08-$0.09 +$0.01$14M$9.9M N/A Details
2/26/15 Q414 -$0.13-$0.08 -$0.05N/A$9.6M N/A Details
11/9/15 Q315 -$0.12-$0.09 -$0.03$6.53M$10.59M N/A Details
5/7/15 Q115 -$0.10-$0.11 +$0.01$9.9M$9.7M N/A Details
8/9/16 Q216 -$0.29-$0.25 -$0.04$2.5M$8.03M N/A Details
11/7/13 Q313 N/A-$0.06 N/A N/A$4.56M N/A N/A N/A
3/10/14 Q413 -$0.07-$0.08 +$0.01$8.75M$6.22M N/A Details
11/5/14 Q314 -$0.08-$0.07 -$0.01$8.2M$9.2M N/A Details